Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Erik Osterman"'
Publikováno v:
BMJ Open, Vol 13, Iss 11 (2023)
Objectives The present study aimed to investigate if and how the panorama of acute cholecystitis changed in 2020 in Sweden. Seven aspects were identified, the incidence of cholecystitis, the Tokyo grade, the timing of diagnosis and treatment, the pro
Externí odkaz:
https://doaj.org/article/c0c31203d7584255974e68e984e9f5ac
Autor:
Erik Osterman, Louise Helenius, Christina Larsson, Sofia Jakobsson, Tamali Majumder, Anders Blomberg, Jennie Wickenberg, Fredrik Linder
Publikováno v:
BMC Gastroenterology, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background International guidelines recommend emergency cholecystectomy for acute cholecystitis in patients who are healthy or have mild systemic disease (ASA1-2). Surgery is also an option for patients with severe systemic disease (ASA3) in
Externí odkaz:
https://doaj.org/article/b53f6349df3a4b45b40d46506eb4f6a6
Autor:
Israa Imam, Tobias Sjöblom, Klara Hammarström, Emerik Osterlund, Bengt Glimelius, Erik Osterman
BACKGROUND The completeness and accuracy of the registration of synchronous metastases and recurrences in the Swedish Colorectal Cancer Registry has not been investigated. Knowing how accurate these parameters are in the registry is a prerequisite to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14b63998018021e14c1eb269c92b190f
Autor:
Erik Osterman, Joakim Ekström, Hartwig Kørner, Bengt Glimelius, Tor Åge Myklebust, Marianne Grønlie Guren, Tobias Sjöblom
Publikováno v:
Acta Oncologica
Background Prediction models are useful tools in the clinical management of colon cancer patients, particularly when estimating the recurrence rate and, thus, the need for adjuvant treatment. However, the most used models (MSKCC, ACCENT) are based on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::081238cb2f04d41c2d829b5b80c1827f
https://hdl.handle.net/11250/2878579
https://hdl.handle.net/11250/2878579
Autor:
Erik Osterman, Klara Hammarström, Israa Imam, Emerik Österlund, Tobias Sjöblom, Bengt Glimelius
Publikováno v:
Cancers
Cancers, Vol 12, Iss 3308, p 3308 (2020)
Cancers, Vol 12, Iss 3308, p 3308 (2020)
Simple Summary Evidence indicates that recurrence risk after colon cancer today is less than it was when trials performed decades ago showed that adjuvant chemotherapy reduces the risk and prolong disease-free and overall survival. After rectal cance
Publikováno v:
Annals of Surgical Oncology
Background The purpose of this study was to investigate whether pT3–4 and pN-subclassifications, lymph-node ratio (LNR), tumour deposits, pre- and postoperative carcinoembryonic antigen (CEA), and C-reactive protein (CRP)—all parameters commonly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44178b5874c0d791099920a5acc8b105
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-400792
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-400792
Autor:
Bengt Glimelius, Erik Osterman
Publikováno v:
Cancers
Cancers, Vol 12, Iss 2289, p 2289 (2020)
Cancers, Vol 12, Iss 2289, p 2289 (2020)
The value of adjuvant chemotherapy in elderly patients has been the subject of many overviews, with opinions varying from “not effective”, since randomized trials have not been performed, to “as effective as in young individuals”, based upon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::5a2293de71567e980c3511163ef9d6db
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-424757
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-424757
Autor:
Bengt Glimelius, Erik Osterman
Publikováno v:
Diseases of the Colon & Rectum. 61:1016-1025
BACKGROUND: Developments in the quality of care of patients with colon cancer have improved surgical outcome and thus the need for adjuvant chemotherapy. OBJECTIVE: To investigate the recurrence rate in a large population-based cohort after modern st
Autor:
Erik Osterman, Bengt Glimelius
Publikováno v:
Annals of Surgical Oncology
ASO Author Reflections : Emerging Risk Factors in Colon Cancer-End of the Line for Clinomics?
Autor:
Erick Moen, William Graf, Brian Chang, Takamasa Kudo, David Van Valen, Morgan Schwartz, Enrico Borba, Noah F. Greenwald, Vibha Vijayakumar, Erik Osterman, Dylan Bannon, Edward Pao
Publikováno v:
Nature Methods. 18:219-219